Effects of 13-hydroxy SM5887 in combination with other anticancer agents on human tumor cell lines

Investigational New Drugs

Volumn 14, Issue 4, 1996, Pages 357-363

  Takagi, Tatsuya ^a   Yazawa, Yasuo ^a   Suzuki, Kenichi ^a   Yamauchi, Yasuo ^b   Kano, Yasuhiko ^a  

^a TOCHIGI CANCER CENTER   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

13 hydroxy SM5887; Chemotherapy; Drug combination; Isobologram; SM5887

Indexed keywords

13 HYDROXYAMRUBICIN; 4 HYDROPEROXYIFOSFAMIDE; AMRUBICIN; ANTHRACYCLINE DERIVATIVE; ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYTARABINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; METHOTREXATE; MITOMYCIN C; UNCLASSIFIED DRUG; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; DRUG STRUCTURE; HUMAN; HUMAN CELL; OSTEOSARCOMA; PRIORITY JOURNAL; T CELL LEUKEMIA;

EID: 0030464699     PISSN: 01676997     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00180811     Document Type: Article

References (18)

1. Ishizumi K, Ohashi N, Tanno N : Sterospecific total synthesis of 9-aminoanthrocyclines:(+)-9-amino-9-deoxyduanomycin and related compounds. J Org Chem 52:4477-4485, 1987
2. Kashiwazaki Y, Morisada S, Fukui M, Yanagi Y: Antitumor activity of a novel anthracycline, SM5887(1). Proc Jpn Cancer Assoc 44th Annu Meet 259, 1985
3. Suzuki T, Arai M, Iwasaki T, Yamamoto H, Kanda H: The cardiotoxicity of a new anthracycline, SM5887, in rabbits. Proc Jpn Cancer Assoc 46th Annu Meet 447, 1987
4. Morisada S, Yanagi Y, Kashiwazaki Y, Fujii M: Toxicological aspects of novel 9-aminoanthracycline, SM5887. Jpn J Cancer Res 80:77-82, 1989
5. Morisada S, Yanagi Y, Noguchi T, Kashiwazaki Y, Fujii M: Antitumor activities of a novel 9-aminocycline (SM5887) against mouse experimental tumors and human tumor xenografts. Jpn J Cancer Res 80:69-76, 1989
6. Inoue K, Ogawa M, Horikoshi N, Mukaiyama T, Itoh Y, Imajoh K, Ozeki H, Nagamine D, Shinagawa K: Phase I and pharmacokinetic study of SM5887, a new anthracycline derivative. Invest New Drugs 7:213-218, 1989
7. Masaoka T, Kuraishi Y, Toki H, Shirakawa S, Ogawa M, The SM5887 Malignant Lymphoma Study Group: A phase II study of the SM5887, a novel 9-aminoanthracycline, for malignant lymphoma. 18th Int Congr Chemother 857, 1993
8. Hiraki S, Shinkai T, Furuse K, Fukuoka M, Ohnoshi T, Kimura I, The SM5887 Lung Cancer Study Group: A phase II study of the SM5887, a novel 9-aminoanthracycline, for non-small cell lung cancer. 18th Int Congr Chemother 866, 1993
9. Tsushima T, Matsumura Y, Komashi K, Akebi N, Tanahashi T, Asahi T, Ohmori H, The SM5887 Bladder Cancer Study Group: Intravesical chemotherapy with SM5887, a novel 9-aminoanthracyline, in patients with superficial bladder cancer - Phase I and II studies. 18th Int Congr Chemother 1026, 1993
10. Masaoka T, Ogawa M, Miura T, Kano Y, Hirano M, Tatsumi N, Nakajima N, The SM5887 Malignant Lymphoma Study Group: Late phase II studies of SM5887 against malignant lymphoma (double blind study, CHOP versus SM5887-COP). Proc Jpn Clin Hematol 35:1008, 1994
11. Morisada S, Noguchi T, Fukui M, Yanagi Y: Cellular pharmacokinetics of a novel anthracycline, SM5887. Proc Jpn Cancer Assoc 45th Annu Meet 1292, 1986
12. Mosmann T: Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assay. J Immunol Meth 65:55-63, 1983
13. Steel GG, Peckham MJ: Exploitable mechanism in combined radiotherapy-chemotherapy: the concept of additivity. Int J Radiat Oncol 5:85-91, 1979
14. Kano Y, Sakamoto S, Ksahara T, Akutsu M, Inoue Y, Miura Y: In vitro effects of amsacrine in combination with other anticancer agents. Leukemia Res 15:1059-1066, 1991
15. Kano Y, Ohnuma T, Okano T, Holland JF: Effects of vincristine in combination with methotrexate and other anticancer agents in human acute lymphoblastic leukemia cells in culture. Cancer Res 48:351-356, 1988
16. Kano Y, Suzuki K, Akutsu M, Suda K, Inoue Y, Yoshida M, Sakamoto S, Miura S: Effects of CPT-11 in combination with other anticancer agents in culture. Int J Cancer 50:605-610, 1992
17. Myers CE, Chabner BA: Anthracyclines. In: Chabner BA, Collins JM (eds) Cancer Chemotherapy - Principle and Practice. Lippincott Company, Philadelphia J.B., 1990, pp 356-381
18. Akutsu M, Suda K, Kano Y, Sakamoto S, Miura Y: The effect of doxorubicin in combination with other antitumor agents in vitro. Proc Jpn Clin Hematol 32:1408, 1990